Sitemap
February 22, 2005 Articles
Filter by Available Specialty
- Drug companies spent more than $38 billion on R&D
- European authorities announce regulatory action on COX-2 inhibitors
- ILM removal not always necessary in stage 3 macular holes
- Microscope-mounted OCT showed anterior segment structures intraoperatively
- Study identifies risk factors for accommodative esotropia in hyperopic children